Cargando…
LOX-1: A potential driver of cardiovascular risk in SLE patients
Traditional cardiovascular disease (CVD) risk factors, such as hypertension, dyslipidemia and diabetes do not explain the increased CVD burden in systemic lupus erythematosus (SLE). The oxidized-LDL receptor, LOX-1, is an inflammation-induced receptor implicated in atherosclerotic plaque formation i...
Autores principales: | Sagar, Divya, Gaddipati, Ranjitha, Ongstad, Emily L., Bhagroo, Nicholas, An, Ling-Ling, Wang, Jingya, Belkhodja, Mehdi, Rahman, Saifur, Manna, Zerai, Davis, Michael A., Hasni, Sarfaraz, Siegel, Richard, Sanjuan, Miguel, Grimsby, Joseph, Kolbeck, Roland, Karathanasis, Sotirios, Sims, Gary P., Gupta, Ruchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077835/ https://www.ncbi.nlm.nih.gov/pubmed/32182251 http://dx.doi.org/10.1371/journal.pone.0229184 |
Ejemplares similares
-
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
por: Wang, Shu, et al.
Publicado: (2018) -
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
por: Rahman, Saifur, et al.
Publicado: (2019) -
Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019) -
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020) -
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus
por: Smith, Michael A., et al.
Publicado: (2019)